ABVC BioPharma

PriceABVC BioPharma

ABVC

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Historical stock price chart and annual return over the past years

-96%

5 years

% Total

ABVC
-47%

5 years

Annual Return

ABVC